These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 28280892)
1. Antidepressant pharmacotherapy in old-age depression-a review and clinical approach. Pruckner N; Holthoff-Detto V Eur J Clin Pharmacol; 2017 Jun; 73(6):661-667. PubMed ID: 28280892 [TBL] [Abstract][Full Text] [Related]
2. If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Connolly KR; Thase ME Drugs; 2011 Jan; 71(1):43-64. PubMed ID: 21175239 [TBL] [Abstract][Full Text] [Related]
6. Evidence-based pharmacotherapy of treatment-resistant unipolar depression. Dold M; Kasper S Int J Psychiatry Clin Pract; 2017 Mar; 21(1):13-23. PubMed ID: 27848269 [TBL] [Abstract][Full Text] [Related]
7. Antidepressants for depression in patients with dementia: a review of the literature. Leong C Consult Pharm; 2014 Apr; 29(4):254-63. PubMed ID: 24704894 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. Kok RM; Nolen WA; Heeren TJ J Affect Disord; 2012 Dec; 141(2-3):103-15. PubMed ID: 22480823 [TBL] [Abstract][Full Text] [Related]
9. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Thomas SJ; Shin M; McInnis MG; Bostwick JR Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531 [TBL] [Abstract][Full Text] [Related]
10. [How to treat and manage unsatisfactory response?]. El-Hage W; Fakra E Encephale; 2016 Feb; 42(1 Suppl 1):1S39-47. PubMed ID: 26879256 [TBL] [Abstract][Full Text] [Related]
11. [Antidepressant and antipsychotic drug prescribing in Lombardy]. Percudani M; Barbui C; Fortino I; Tansella M; Petrovich L Epidemiol Psichiatr Soc; 2006; 15(1):59-70. PubMed ID: 16584104 [TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression. Bobo WV; Shelton RC Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487 [TBL] [Abstract][Full Text] [Related]
13. Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy. Rogóż Z Pharmacol Rep; 2013; 65(6):1535-44. PubMed ID: 24553002 [TBL] [Abstract][Full Text] [Related]
14. Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic study. Köhler S; Unger T; Hoffmann S; Steinacher B; Fydrich T; Bschor T Pharmacopsychiatry; 2013 Mar; 46(2):69-76. PubMed ID: 23093475 [TBL] [Abstract][Full Text] [Related]
15. Antidepressants in the elderly. Chiu HF Int J Clin Pract; 1997 Sep; 51(6):369-74. PubMed ID: 9489065 [TBL] [Abstract][Full Text] [Related]
16. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychotics. Hill L; Lee KC Ann Pharmacother; 2013 Jan; 47(1):75-89. PubMed ID: 23341158 [TBL] [Abstract][Full Text] [Related]
18. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression. Ricken R; Ulrich S; Schlattmann P; Adli M Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Depression in Patients with Concomitant Cardiac Disease. Teply RM; Packard KA; White ND; Hilleman DE; DiNicolantonio JJ Prog Cardiovasc Dis; 2016; 58(5):514-28. PubMed ID: 26562328 [TBL] [Abstract][Full Text] [Related]
20. Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice. Prescrire Int; 2011 May; 20(116):128-33. PubMed ID: 21648180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]